122例肝门胆管癌的治疗及预后分析  

ANALYSIS OF SURGICAL TREATMENT AND PROGNOSTIC FACTORS FOR 122 CASES HILAR CHOLANGIOCARCINOMA

作　　者：赵建勋[1] 乔岐禄[1] 高嵩[1] 张环[1] 刘荫华[1] 王嘉琪[1] 张宝善[1] 

机构地区：[1]北京大学第一医院普外科,100034

出　　处：《中国现代医学杂志》2001年第4期15-17,共3页China Journal of Modern Medicine

摘　　要：目的 :探讨肝门胆管癌的治疗方法及其预后。方法 :回顾性比较不同治疗方法的应用和效果 ,分析预后因素。结果 :根治性切除手术组的 1,2 ,3和 5年生存率分别为 92 .49% ,5 9.85 % ,45 .0 6 % ,2 5 .75 % ;非根治切除手术组分别为 36 .6 9% ,7.34% ,3 .6 7% ,和 3.5 7% ;开腹探查的各种姑息性引流手术和非手术引流组仅有 1年生存率 ,分别为 2 6 %和 30 .38%。结论 :根治性切除术疗效最佳 ,肿瘤分化程度 ,手术切缘残癌及淋巴结移状况对预后有显著影响。Objective:To explore surgical treatments and the prognosis of hilar cholangiocarcinoma.Methods:The approach and effect with different surgical treatments were compared in this retrospective study,and the prognostic factors analyzd.Results:The 1-,2-,3-and 5-year survival rate in the group after a curative resection was 92.49%,59.85%,45.06%and 25.75%;and 36.69%,7.34%,3.67%and 3.57% in the group with a palliative resection;the group with a palliative draining operations or with a nonoperative managements had 1-year survival rate only,was 26% and 30.38%,respectively.Conclusions:The curative resection was the best way to obtain better prognosis,tumor differentiation,residual tumor of margin and lymph node metastases were considered to have significant effect on prognosis.

关 键 词：肝门胆管癌 预后 手术切缘 胆道镜 治疗 

分 类 号：R735.7[医药卫生—肿瘤]